Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of Fibrin Sealant 2 in Vascular Surgical Procedures

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: None
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Male and female subjects, 18 years or older, requiring elective, primary or repeat vascular procedures with at least one end-to-side femoral or upper extremity vascular access arterial anastomosis (e.g. femoral-femoral, femoral-popliteal, femoral-tibial, ilio-femoral, aorto-bifemoral, abdominal aortic aneurysm, upper extremity vascular access for dialysis) using uncoated or heparin-coated PTFE grafts and polypropylene sutures (size 5-0 or 6-0) with a 1:1 needle-to-thread ratio.~* Following initial arterial clamp release, the study surgeon determines that adjunctive measures are needed to obtain haemostasis at the SAS.~* Subjects must be willing to and capable of participating in the study, and provided written informed consent.~Exclusion Criteria:~* Subjects undergoing re-vascularisation using autologous conduits (e.g. saphenous vein) or prosthetic material other than uncoated or heparin-coated PTFE.~* Subjects undergoing emergency surgery.~* Subjects with any intra-operative findings that may preclude conduct of the study procedure.~* Subjects with known intolerance to heparin, blood products or to one of the components of the study product.~* Subjects unwilling to receive blood products.~* Subjects with autoimmune immunodeficiency diseases (including known HIV).~* Subjects who are known, current alcohol and / or drug abusers.~* Subjects who have participated in another investigational drug or device research study within 30 days of enrolment.~* Female subjects who are pregnant or nursing.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).